A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis

Background and objectivesB-cell activating factor of the TNF family (BAFF) plays a role in (auto)antibody production. Elevated serum levels (sBAFF) were found in patients with myositis.Associations of elevated sBAFF with a SNP in the 5´regulatory region of the BAFF genewere reported in patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2016-02, Vol.75 (Suppl 1), p.A71-A72
Hauptverfasser: Kryštůfková, O, Svitálková, T, Hulejová, H, Světlá, M, Pleštilová, L, Pavlíková, M, Mišunová, M, Klein, M, Mann, H, Novota, P, Vencovský, J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A72
container_issue Suppl 1
container_start_page A71
container_title Annals of the rheumatic diseases
container_volume 75
creator Kryštůfková, O
Svitálková, T
Hulejová, H
Světlá, M
Pleštilová, L
Pavlíková, M
Mišunová, M
Klein, M
Mann, H
Novota, P
Vencovský, J
description Background and objectivesB-cell activating factor of the TNF family (BAFF) plays a role in (auto)antibody production. Elevated serum levels (sBAFF) were found in patients with myositis.Associations of elevated sBAFF with a SNP in the 5´regulatory region of the BAFF genewere reported in patients with autoimmune diseases, together with TTTT haplotype of the four SNPs located upstream of the BAFF gene. TTTT was associated with myositis in Czech patients, independently from the HLA-DRB1*03 allele. Here we evaluate associations of sBAFF with particular SNPs, anti-Jo-1-autoantibodies, HLA-DRB1*03, ILD and disease activity in myositis.Materials and methodsThe SNPs (rs9514828:871C>T, rs9514827:-2841T>C, rs3759467:-2704T>C and rs1041569:-2701T >A) were analysed by direct DNA sequencing in 311 patients with myositis (age:58.0 ± 14.5(years), females = 74%) and 113 healthy controls (age:40.6 ± 14.3, females = 70%). Levels of sBAFF were measured by ELISA. Autoantibodies were detected by immunoprecipitation. Multivariable logistic regression model for presence of anti-Jo-1-autoantibodies and nonparametric tests for group comparisons and correlation analysis were used.ResultsAnalysed patients cohort included 150 DM, 139 PM, 51% ILD and 24% anti-Jo-1-positive patients. HLA-DRB1*03 was present in 45% of patients and 16% of controls. Higher s-BAFF levels were detected in: patients compared to healthy controls (p < 0.0001), patients with anti-Jo-1-autoantibodies compared to autoantibody negative (p = 0.02), patients with early (duration≤ 6 month; n = 114) compared to late disease (p = 0.038) and were associated with creatine kinase (CK) levels (rho=0.36;p < 0.0001) and disease duration (rho=-0.2;p = 0.0007).Logistic regression model explaining 49% (McFadden R2=0.49) of the data variability included, besides ILD (OR = 27.24;p < 0.0001) and HLA-DRB1*03 (OR = 5.26;p = 0.0009), significant additive effect of the BAFF gene SNPs: -2841T allele (OR = 2.55;p = 0.028) and a -871TT genotype (OR = 7.75;p = 0.007). The alternative substitution of CK concentration (OR = 1.48;p = 0.175) with sBAFF (OR = 0.67; p = 0.037)lowered model stability (R2 = 0.38). However, the additive effect of -871T allele to sBAFF levels in anti-Jo-1-positive patients compared to autoantibody-negative (higher in -871TT:p = 0.023 and -871CT:p = 0.043) and the opposite association in -2841TT genotype (higher in -2841CC: p = 0.033 and -2841CT:p = 0.068)were seen.ConclusionIn addition to ILD and HLA-DRB1*03 allele,
doi_str_mv 10.1136/annrheumdis-2016-209124.170
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901702763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322498285</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1273-13527709da41d88c38520df1e756093fa8a719066ca5638d1923faa3c2f048a23</originalsourceid><addsrcrecordid>eNqVkEtLAzEUhYMoWKv_IdB1ah4zSQZXpfiCokJ1HdKZTCdj52GSKt25cemf9JeYOi7cusgN93C-c-EAMCF4Sgjj57ptXWW2TWE9opjwODJCkykR-ACMSMJlVDg-BCOMMUNJxsUxOPG-jiuWRI7A5yyb4uTr_WN597CEtoWhMnClyxKuTWugdvF53-VWB1PANxuqaMqd0T6uzvpn2JVQt8GiukME9Z23wb7asItiASu7rqA3btsMmRvzajZ-f6bXwZo2-CGy2f1w_hQclXrjzdnvPwZPV5eP8xu0uL--nc8WaEWoYIiwlAqBs0InpJAyZzKluCiJESnHGSu11IJkmPNcp5zJgmQ0iprltMSJ1JSNwWTI7V33sjU-qLrbujaeVJGL7VHBWXRdDK7cdd47U6re2Ua7nSJY7ftXf_pX-_7V0L-KCZHmA71q6n-B36dNjr8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901702763</pqid></control><display><type>article</type><title>A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis</title><source>BMJ Journals - NESLi2</source><creator>Kryštůfková, O ; Svitálková, T ; Hulejová, H ; Světlá, M ; Pleštilová, L ; Pavlíková, M ; Mišunová, M ; Klein, M ; Mann, H ; Novota, P ; Vencovský, J</creator><creatorcontrib>Kryštůfková, O ; Svitálková, T ; Hulejová, H ; Světlá, M ; Pleštilová, L ; Pavlíková, M ; Mišunová, M ; Klein, M ; Mann, H ; Novota, P ; Vencovský, J</creatorcontrib><description>Background and objectivesB-cell activating factor of the TNF family (BAFF) plays a role in (auto)antibody production. Elevated serum levels (sBAFF) were found in patients with myositis.Associations of elevated sBAFF with a SNP in the 5´regulatory region of the BAFF genewere reported in patients with autoimmune diseases, together with TTTT haplotype of the four SNPs located upstream of the BAFF gene. TTTT was associated with myositis in Czech patients, independently from the HLA-DRB1*03 allele. Here we evaluate associations of sBAFF with particular SNPs, anti-Jo-1-autoantibodies, HLA-DRB1*03, ILD and disease activity in myositis.Materials and methodsThe SNPs (rs9514828:871C&gt;T, rs9514827:-2841T&gt;C, rs3759467:-2704T&gt;C and rs1041569:-2701T &gt;A) were analysed by direct DNA sequencing in 311 patients with myositis (age:58.0 ± 14.5(years), females = 74%) and 113 healthy controls (age:40.6 ± 14.3, females = 70%). Levels of sBAFF were measured by ELISA. Autoantibodies were detected by immunoprecipitation. Multivariable logistic regression model for presence of anti-Jo-1-autoantibodies and nonparametric tests for group comparisons and correlation analysis were used.ResultsAnalysed patients cohort included 150 DM, 139 PM, 51% ILD and 24% anti-Jo-1-positive patients. HLA-DRB1*03 was present in 45% of patients and 16% of controls. Higher s-BAFF levels were detected in: patients compared to healthy controls (p &lt; 0.0001), patients with anti-Jo-1-autoantibodies compared to autoantibody negative (p = 0.02), patients with early (duration≤ 6 month; n = 114) compared to late disease (p = 0.038) and were associated with creatine kinase (CK) levels (rho=0.36;p &lt; 0.0001) and disease duration (rho=-0.2;p = 0.0007).Logistic regression model explaining 49% (McFadden R2=0.49) of the data variability included, besides ILD (OR = 27.24;p &lt; 0.0001) and HLA-DRB1*03 (OR = 5.26;p = 0.0009), significant additive effect of the BAFF gene SNPs: -2841T allele (OR = 2.55;p = 0.028) and a -871TT genotype (OR = 7.75;p = 0.007). The alternative substitution of CK concentration (OR = 1.48;p = 0.175) with sBAFF (OR = 0.67; p = 0.037)lowered model stability (R2 = 0.38). However, the additive effect of -871T allele to sBAFF levels in anti-Jo-1-positive patients compared to autoantibody-negative (higher in -871TT:p = 0.023 and -871CT:p = 0.043) and the opposite association in -2841TT genotype (higher in -2841CC: p = 0.033 and -2841CT:p = 0.068)were seen.ConclusionIn addition to ILD and HLA-DRB1*03 allele, SNPs of the promotor region of the BAFF gene, -871C &gt;T and -2841T &gt;C, increase the risk of having anti-Jo-1-autoantibodies and high sBAFF levels in patients with myositis.AcknowledgementsMZČR-Institutional support of research organisation-00023728.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2016-209124.170</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><ispartof>Annals of the rheumatic diseases, 2016-02, Vol.75 (Suppl 1), p.A71-A72</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/75/Suppl_1/A71.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/75/Suppl_1/A71.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Kryštůfková, O</creatorcontrib><creatorcontrib>Svitálková, T</creatorcontrib><creatorcontrib>Hulejová, H</creatorcontrib><creatorcontrib>Světlá, M</creatorcontrib><creatorcontrib>Pleštilová, L</creatorcontrib><creatorcontrib>Pavlíková, M</creatorcontrib><creatorcontrib>Mišunová, M</creatorcontrib><creatorcontrib>Klein, M</creatorcontrib><creatorcontrib>Mann, H</creatorcontrib><creatorcontrib>Novota, P</creatorcontrib><creatorcontrib>Vencovský, J</creatorcontrib><title>A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis</title><title>Annals of the rheumatic diseases</title><description>Background and objectivesB-cell activating factor of the TNF family (BAFF) plays a role in (auto)antibody production. Elevated serum levels (sBAFF) were found in patients with myositis.Associations of elevated sBAFF with a SNP in the 5´regulatory region of the BAFF genewere reported in patients with autoimmune diseases, together with TTTT haplotype of the four SNPs located upstream of the BAFF gene. TTTT was associated with myositis in Czech patients, independently from the HLA-DRB1*03 allele. Here we evaluate associations of sBAFF with particular SNPs, anti-Jo-1-autoantibodies, HLA-DRB1*03, ILD and disease activity in myositis.Materials and methodsThe SNPs (rs9514828:871C&gt;T, rs9514827:-2841T&gt;C, rs3759467:-2704T&gt;C and rs1041569:-2701T &gt;A) were analysed by direct DNA sequencing in 311 patients with myositis (age:58.0 ± 14.5(years), females = 74%) and 113 healthy controls (age:40.6 ± 14.3, females = 70%). Levels of sBAFF were measured by ELISA. Autoantibodies were detected by immunoprecipitation. Multivariable logistic regression model for presence of anti-Jo-1-autoantibodies and nonparametric tests for group comparisons and correlation analysis were used.ResultsAnalysed patients cohort included 150 DM, 139 PM, 51% ILD and 24% anti-Jo-1-positive patients. HLA-DRB1*03 was present in 45% of patients and 16% of controls. Higher s-BAFF levels were detected in: patients compared to healthy controls (p &lt; 0.0001), patients with anti-Jo-1-autoantibodies compared to autoantibody negative (p = 0.02), patients with early (duration≤ 6 month; n = 114) compared to late disease (p = 0.038) and were associated with creatine kinase (CK) levels (rho=0.36;p &lt; 0.0001) and disease duration (rho=-0.2;p = 0.0007).Logistic regression model explaining 49% (McFadden R2=0.49) of the data variability included, besides ILD (OR = 27.24;p &lt; 0.0001) and HLA-DRB1*03 (OR = 5.26;p = 0.0009), significant additive effect of the BAFF gene SNPs: -2841T allele (OR = 2.55;p = 0.028) and a -871TT genotype (OR = 7.75;p = 0.007). The alternative substitution of CK concentration (OR = 1.48;p = 0.175) with sBAFF (OR = 0.67; p = 0.037)lowered model stability (R2 = 0.38). However, the additive effect of -871T allele to sBAFF levels in anti-Jo-1-positive patients compared to autoantibody-negative (higher in -871TT:p = 0.023 and -871CT:p = 0.043) and the opposite association in -2841TT genotype (higher in -2841CC: p = 0.033 and -2841CT:p = 0.068)were seen.ConclusionIn addition to ILD and HLA-DRB1*03 allele, SNPs of the promotor region of the BAFF gene, -871C &gt;T and -2841T &gt;C, increase the risk of having anti-Jo-1-autoantibodies and high sBAFF levels in patients with myositis.AcknowledgementsMZČR-Institutional support of research organisation-00023728.</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkEtLAzEUhYMoWKv_IdB1ah4zSQZXpfiCokJ1HdKZTCdj52GSKt25cemf9JeYOi7cusgN93C-c-EAMCF4Sgjj57ptXWW2TWE9opjwODJCkykR-ACMSMJlVDg-BCOMMUNJxsUxOPG-jiuWRI7A5yyb4uTr_WN597CEtoWhMnClyxKuTWugdvF53-VWB1PANxuqaMqd0T6uzvpn2JVQt8GiukME9Z23wb7asItiASu7rqA3btsMmRvzajZ-f6bXwZo2-CGy2f1w_hQclXrjzdnvPwZPV5eP8xu0uL--nc8WaEWoYIiwlAqBs0InpJAyZzKluCiJESnHGSu11IJkmPNcp5zJgmQ0iprltMSJ1JSNwWTI7V33sjU-qLrbujaeVJGL7VHBWXRdDK7cdd47U6re2Ua7nSJY7ftXf_pX-_7V0L-KCZHmA71q6n-B36dNjr8</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Kryštůfková, O</creator><creator>Svitálková, T</creator><creator>Hulejová, H</creator><creator>Světlá, M</creator><creator>Pleštilová, L</creator><creator>Pavlíková, M</creator><creator>Mišunová, M</creator><creator>Klein, M</creator><creator>Mann, H</creator><creator>Novota, P</creator><creator>Vencovský, J</creator><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201602</creationdate><title>A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis</title><author>Kryštůfková, O ; Svitálková, T ; Hulejová, H ; Světlá, M ; Pleštilová, L ; Pavlíková, M ; Mišunová, M ; Klein, M ; Mann, H ; Novota, P ; Vencovský, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1273-13527709da41d88c38520df1e756093fa8a719066ca5638d1923faa3c2f048a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kryštůfková, O</creatorcontrib><creatorcontrib>Svitálková, T</creatorcontrib><creatorcontrib>Hulejová, H</creatorcontrib><creatorcontrib>Světlá, M</creatorcontrib><creatorcontrib>Pleštilová, L</creatorcontrib><creatorcontrib>Pavlíková, M</creatorcontrib><creatorcontrib>Mišunová, M</creatorcontrib><creatorcontrib>Klein, M</creatorcontrib><creatorcontrib>Mann, H</creatorcontrib><creatorcontrib>Novota, P</creatorcontrib><creatorcontrib>Vencovský, J</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kryštůfková, O</au><au>Svitálková, T</au><au>Hulejová, H</au><au>Světlá, M</au><au>Pleštilová, L</au><au>Pavlíková, M</au><au>Mišunová, M</au><au>Klein, M</au><au>Mann, H</au><au>Novota, P</au><au>Vencovský, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2016-02</date><risdate>2016</risdate><volume>75</volume><issue>Suppl 1</issue><spage>A71</spage><epage>A72</epage><pages>A71-A72</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background and objectivesB-cell activating factor of the TNF family (BAFF) plays a role in (auto)antibody production. Elevated serum levels (sBAFF) were found in patients with myositis.Associations of elevated sBAFF with a SNP in the 5´regulatory region of the BAFF genewere reported in patients with autoimmune diseases, together with TTTT haplotype of the four SNPs located upstream of the BAFF gene. TTTT was associated with myositis in Czech patients, independently from the HLA-DRB1*03 allele. Here we evaluate associations of sBAFF with particular SNPs, anti-Jo-1-autoantibodies, HLA-DRB1*03, ILD and disease activity in myositis.Materials and methodsThe SNPs (rs9514828:871C&gt;T, rs9514827:-2841T&gt;C, rs3759467:-2704T&gt;C and rs1041569:-2701T &gt;A) were analysed by direct DNA sequencing in 311 patients with myositis (age:58.0 ± 14.5(years), females = 74%) and 113 healthy controls (age:40.6 ± 14.3, females = 70%). Levels of sBAFF were measured by ELISA. Autoantibodies were detected by immunoprecipitation. Multivariable logistic regression model for presence of anti-Jo-1-autoantibodies and nonparametric tests for group comparisons and correlation analysis were used.ResultsAnalysed patients cohort included 150 DM, 139 PM, 51% ILD and 24% anti-Jo-1-positive patients. HLA-DRB1*03 was present in 45% of patients and 16% of controls. Higher s-BAFF levels were detected in: patients compared to healthy controls (p &lt; 0.0001), patients with anti-Jo-1-autoantibodies compared to autoantibody negative (p = 0.02), patients with early (duration≤ 6 month; n = 114) compared to late disease (p = 0.038) and were associated with creatine kinase (CK) levels (rho=0.36;p &lt; 0.0001) and disease duration (rho=-0.2;p = 0.0007).Logistic regression model explaining 49% (McFadden R2=0.49) of the data variability included, besides ILD (OR = 27.24;p &lt; 0.0001) and HLA-DRB1*03 (OR = 5.26;p = 0.0009), significant additive effect of the BAFF gene SNPs: -2841T allele (OR = 2.55;p = 0.028) and a -871TT genotype (OR = 7.75;p = 0.007). The alternative substitution of CK concentration (OR = 1.48;p = 0.175) with sBAFF (OR = 0.67; p = 0.037)lowered model stability (R2 = 0.38). However, the additive effect of -871T allele to sBAFF levels in anti-Jo-1-positive patients compared to autoantibody-negative (higher in -871TT:p = 0.023 and -871CT:p = 0.043) and the opposite association in -2841TT genotype (higher in -2841CC: p = 0.033 and -2841CT:p = 0.068)were seen.ConclusionIn addition to ILD and HLA-DRB1*03 allele, SNPs of the promotor region of the BAFF gene, -871C &gt;T and -2841T &gt;C, increase the risk of having anti-Jo-1-autoantibodies and high sBAFF levels in patients with myositis.AcknowledgementsMZČR-Institutional support of research organisation-00023728.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/annrheumdis-2016-209124.170</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2016-02, Vol.75 (Suppl 1), p.A71-A72
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1901702763
source BMJ Journals - NESLi2
title A9.04 SNPS in the baff gene are associated with increased risk of anti-jo-1-positivity and high serum baff levels in patients with myositis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A11%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A9.04%E2%80%85SNPS%20in%20the%20baff%20gene%20are%20associated%20with%20increased%20risk%20of%20anti-jo-1-positivity%20and%20high%20serum%20baff%20levels%20in%20patients%20with%20myositis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Kry%C5%A1t%C5%AFfkov%C3%A1,%20O&rft.date=2016-02&rft.volume=75&rft.issue=Suppl%201&rft.spage=A71&rft.epage=A72&rft.pages=A71-A72&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2016-209124.170&rft_dat=%3Cproquest_cross%3E4322498285%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901702763&rft_id=info:pmid/&rfr_iscdi=true